Fierce Biotech

Biotech Giants and Investors Gather to Solve the Commercialisation Puzzle This May in Hong Kong

Biotech executives, investors, and R&D leaders all face the same burning question in 2026: How do we scale breakthroughs from ...
Hosted on MSN

Krystal Biotech targets global expansion for VYJUVEK with launches in Germany, France, and Japan amid pipeline acceleration

CEO Krish Krishnan opened the call highlighting the continued momentum in the VYJUVEK launch. He stated, "In Q3, VYJUVEK launch continued to build momentum and the updated U.S. label clearly ...
Morningstar

'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week

PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, ...
The Desert Sun

Xi’an Aoge Biotech: Global Leading Cosmetic Raw Materials Manufacturer Defining the Future of Clean Beauty

SHAANXI, SHAANXI, CHINA, February 10, 2026 /EINPresswire.com/ — Xi’an Aoge Biotech: Global Leading Cosmetic Raw Materials Manufacturer Defining the Future of ...
Seeking Alpha

Krystal Biotech targets global VYJUVEK expansion with Italy launch in H2 2026 while maintaining 90%–95% gross margin outlook

The company expects to expand global distributor agreements to cover over 40 countries in 2026 and to finalize VYJUVEK pricing and launch in Italy in the second half of 2026. Management reaffirmed ...
Morningstar

Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics

GSK will be responsible for all subsequent global clinical development, regulatory submissions, and commercialization activities. Dr. Dong Xie, Chairman and CEO of Frontier Biotech, stated: "We are ...